Atlanta, United States
Lucid Scientific, headquartered in the United States, is carving a niche in the Biotechnology industry with its innovative product, the Resipher, known for its slogan: "Creators of the Resipher real-time cellular activity monitor. Continuous, immediate, and accurate cell analysis." Founded in 2012, the company has developed the world's first real-time cell culture monitor that measures oxygen consumption in standard multi-well plates, providing continuous, in-incubator insights.
With a recent $7.00M Series A investment secured on 05 September 2023, Lucid Scientific is backed by prominent investors like Dynamk Capital, GRA Venture Fund, and IAG Capital Partners. This funding round underscores the confidence investors have in Lucid's potential to advance cell analysis technology continuously. As the biomedical field increasingly moves towards real-time data, Lucid is well-positioned to capitalize on this trend, providing a crucial tool for researchers and clinicians alike.
